John R. Webb
8Patents
6h-index
8Co-inventors
48Inventor score
Filing activity: Sep 22, 1995 → Jun 4, 2001
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5834592A | Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis | Emerging Cross-Sectional Technologies | 18 | Expired |
| US6638517B2 | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6613337B1 | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6500437B1 | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6375955B1 | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6365165B1 | Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6607731B1 | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis | Emerging Cross-Sectional Technologies | 5 | Expired |
| US6709661B1 | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis | Emerging Cross-Sectional Technologies | 4 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.